Physiological and pathological actions of sphingosine 1-phosphate - PubMed (original) (raw)
Review
Physiological and pathological actions of sphingosine 1-phosphate
Timothy Hla. Semin Cell Dev Biol. 2004 Oct.
Abstract
Sphingosine 1-phosphate (S1P), a product of sphingomyelin (SM) metabolism, occurs widely in nature. Although, originally described as an intracellular second messenger, its role as an extracellular lipid mediator in higher organisms has recently been shown with the discovery of the G protein-coupled receptors (GRCR) for S1P. In mammals, S1P receptors are widely expressed and are thought to regulate important physiological actions, such as immune cell trafficking, vascular development, vascular tone control, cardiac function, and vascular permeability, among others. In addition, S1P may participate in various pathological conditions. For example, S1P has been implicated as an important mediator in autoimmunity, transplant rejection, cancer, angiogenesis, vascular permeability, female infertility, and myocardial infarction. It is important to emphasize that these findings represent an early understanding of the physiological and pathological roles of S1P. The ubiquity of the mediator and its receptors, as well as the evolutionary conservation of S1P metabolism and action, argues that it is a potent and ubiquitous physiological factor in many contexts, and warrant a fuller understanding of its actions at the molecular, cellular and organismal levels.
Similar articles
- Signaling and biological actions of sphingosine 1-phosphate.
Hla T. Hla T. Pharmacol Res. 2003 May;47(5):401-7. doi: 10.1016/s1043-6618(03)00046-x. Pharmacol Res. 2003. PMID: 12676514 Review. - Sphingosine 1-phosphate as a therapeutic agent.
Spiegel S, Kolesnick R. Spiegel S, et al. Leukemia. 2002 Sep;16(9):1596-602. doi: 10.1038/sj.leu.2402611. Leukemia. 2002. PMID: 12200669 Review. - Sphingosine kinase signalling in immune cells.
Kee TH, Vit P, Melendez AJ. Kee TH, et al. Clin Exp Pharmacol Physiol. 2005 Mar;32(3):153-61. doi: 10.1111/j.1440-1681.2005.04166.x. Clin Exp Pharmacol Physiol. 2005. PMID: 15743396 Review. - Review: novel insights into the regulation of vascular tone by sphingosine 1-phosphate.
Kerage D, Brindley DN, Hemmings DG. Kerage D, et al. Placenta. 2014 Feb;35 Suppl:S86-92. doi: 10.1016/j.placenta.2013.12.006. Epub 2013 Dec 21. Placenta. 2014. PMID: 24411702 Review. - [Sphingosine 1-phosphate receptors: from biology to physiopathology].
Cuvillier O. Cuvillier O. Med Sci (Paris). 2012 Nov;28(11):951-7. doi: 10.1051/medsci/20122811013. Epub 2012 Nov 12. Med Sci (Paris). 2012. PMID: 23171898 French.
Cited by
- Sphingosine-1-phosphate signaling regulates lamellipodia localization of cortactin complexes in endothelial cells.
Lee JF, Ozaki H, Zhan X, Wang E, Hla T, Lee MJ. Lee JF, et al. Histochem Cell Biol. 2006 Sep;126(3):297-304. doi: 10.1007/s00418-006-0143-z. Epub 2006 Jan 14. Histochem Cell Biol. 2006. PMID: 16416022 - S1P lyase regulates DNA damage responses through a novel sphingolipid feedback mechanism.
Kumar A, Oskouian B, Fyrst H, Zhang M, Paris F, Saba JD. Kumar A, et al. Cell Death Dis. 2011 Feb 10;2(2):e119. doi: 10.1038/cddis.2011.3. Cell Death Dis. 2011. PMID: 21368890 Free PMC article. - Membrane Lipid Composition: Effect on Membrane and Organelle Structure, Function and Compartmentalization and Therapeutic Avenues.
Casares D, Escribá PV, Rosselló CA. Casares D, et al. Int J Mol Sci. 2019 May 1;20(9):2167. doi: 10.3390/ijms20092167. Int J Mol Sci. 2019. PMID: 31052427 Free PMC article. Review. - Sphingosine-1-phosphate attenuates lung injury induced by intestinal ischemia/reperfusion in mice: role of inducible nitric-oxide synthase.
Ding R, Han J, Tian Y, Guo R, Ma X. Ding R, et al. Inflammation. 2012 Feb;35(1):158-66. doi: 10.1007/s10753-011-9301-0. Inflammation. 2012. PMID: 21302134 - The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice.
Fukuhara S, Simmons S, Kawamura S, Inoue A, Orba Y, Tokudome T, Sunden Y, Arai Y, Moriwaki K, Ishida J, Uemura A, Kiyonari H, Abe T, Fukamizu A, Hirashima M, Sawa H, Aoki J, Ishii M, Mochizuki N. Fukuhara S, et al. J Clin Invest. 2012 Apr;122(4):1416-26. doi: 10.1172/JCI60746. Epub 2012 Mar 12. J Clin Invest. 2012. PMID: 22406534 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources